Category Archives: Health Care Services

High Content Screening Market – Scope, Size, Share, Analysis Trends, Applications, Growth, and Forecast

The overall high content screening market is expected to grow from USD 506.7 million in 2016 to USD 909.0 million by 2022, at a CAGR of 10.3% from 2017 to 2022.

The major factors driving the growth of the HTS market include initiatives undertaken by pharmaceutical and biotechnology companies, increasing R&D spending, technological advancements in HTS, and the availability of government funding and venture capital investments.

Download PDF Brochure:

High Throughput Screening Market segmentation:

  • By product and service, the reagents & assay kits
  • By technology
  • By end user

****** Softgel Capsules Market: Size, Outlook, Trend and Forecast 2024

Bharat Book Bureau Provides the Trending Market Research Report on “****** Softgel Capsules Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024”under Healthcare Category. The report offers a collection of superior market research, market analysis, competitive intelligence and Market reports.

****** Softgel Capsules Market 2019-2024

Softgel Capsule is a type of capsules with a solid outer shell and inner surrounding a liquid or semi-solid (inner fill) active ingredient that can be incorporated into the outer shell, the inner fill, or both.

Veterinary Software Market hits at a CAGR of 6.1% by 2022

The ****** Veterinary Software Market is projected to reach USD 594 million by 2022 from USD 442 million in 2017, at a CAGR of 6.1%.

The Research report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the Veterinary Software Market, along with revenue estimates & forecasts and market share analysis

The growth of this market is majorly driven by factors such as the rising companion animal ownership, growing animal healthcare expenditure, growing product innovation and software integration, and the consolidation of the veterinary healthcare industry.

Download PDF Brochure

Veterinary Software Market

****** Medical Tapes And Bandages Market: Opportunities And Forecast (2014-2024)

Bharat Book Bureau Provides the Trending Market Research Report on “****** Medical Tapes and Bandages Market: Analysis By Product Type, By Application, By End User, By Region, By Country (2019 Edition): Opportunities and Forecast (2014-2024)”under Medical Devices Category. The report offers a collection of superior market research, market analysis, competitive intelligence and Market reports.

****** Medical Tapes and Bandages Market: Analysis By Product Type (Medical Bandages, Medical Tapes), By Application (Surgery, Trauma & Laceration, Ulcer, Sports Injury, Burn Injury and Others), By End User (Hospitals, Clinics, Ambulatory Surgery Centers, Others), By Region, By Country (2019 Edition): Opportunities and Forecast (2014-2024)

ECMO Machine Market Growing at a CAGR of 4.3%

According to the new market research report ECMO Machine Market is expected to reach USD 305.3 Million by 2021 from USD 247.2 Million in 2016, at a CAGR of 4.3%. A number of key players are competing against each other to expand their existing customer base. Getinge Group (Sweden), Medtronic plc (Ireland), and LivaNova PLC (U.K.) are the top three players of the extracorporeal membrane oxygenation (ECMO) machine market. These players jointly accounted for a share of 65% to 70% of the total ECMO machine market in 2015.

Know more

Fill Finish Manufacturing Market – ****** Industry Dominators | Monetary Growth

Technological advancements in fill-finish products, growth of the biopharmaceutical industry, rising adoption of prefilled syringes, and increase in fill-finish outsourcing are the major factors driving this market.

Product launches remain at the center of the strategic growth initiatives adopted by a majority of key players in the ****** fill-finish manufacturing market. Companies such as Schott (Germany), Stevanato (Italy), Gerresheimer (Germany), Robert Bosch (Germany), and Becton, Dickinson and Company (US) have been focusing on product launches to enhance their market presence. Players also focused on increasing their presence in high-growth markets through inorganic growth strategies, such as partnerships, collaborations, agreements, expansions, and acquisitions.

Monoclonal Antibodies Sterile Injectable Drugs Market Current Trends and Future Aspect Analysis 2017 – 2025

Monoclonal antibodies are produced through cell division from a single ancestral or parent cell. Monoclonal antibodies are a class of antibodies with identical offspring of a hybridoma and are quite precise for a specific site in the body derived from a single clone and can be grown for an indefinite time. Monoclonal antibodies may have monovalent affinity, in that these bind to the same epitope. These have brought about a fundamental change in the pharmaceutical and biotechnology industries and are slated to play a crucial role in clinical protocol in future with further development of these molecular agents. Monoclonal antibodies find applications in the treatment of various diseases, particularly autoimmune, cancer, and inflammatory diseases.

Thalassemia Therapeutics Market Latest Report with Forecast to 2025

****** Thalassemia Therapeutics Market: Overview


Thalassemia is a type of hereditary blood disorder in which an abnormal form of hemoglobin is produced by the human body. It leads to destruction of a large number of blood cells, resulting in anemia. Thalassemia is a genetic disorder and it is caused by genetic mutation or deletion of a specific gene fragment. If only one parent is the carrier of the gene, the offspring may develop thalassemia minor. If both parents are carriers of the disease, there is a possibility of developing a serious form of the disease. There are three types of thalassemia viz. beta thalassemia, alpha thalassemia, and thalassemia minor. The treatment of the disorder depends on its severity and type. In beta thalassemia, the body cannot produce beta globulin. The patients with beta and those with alpha thalassemia manifest more severe symptoms as compared to thalassemia minor. Some of the common symptoms are bone deformities, dark urine, pale skin, and excessive fatigue.

Dendritic Cell and CAR-T Therapies Market Review with Forecast Research Report 2017 – 2025

Dendritic cells are known as accessory cells of the mammalian immune system. Their major function is to process surface antigen of T cells of immune system. Chimeric Antigen Receptor (CAR-T) therapy is an immunotherapy, which is primarily used to treat cancers. Dendritic cells are antigen-presenting cells that are a part of mammalian cells and functions by provoking anti-tumor responses. Dendritic cells can be activated in vivo by genetic engineering. Current cellular immunotherapy treatment therapies are divided into CAR-T, CAR-NK, stem cell therapeutics direct reprogramming, and dendritic cell immunotherapies. Sipuleucel-T is the only approved immunotherapy based on the concept of dendritic cells mechanism, which was approved in 2010 for the treatment of metastatic prostate cancer. In August 2017, the U.S. food drug admiration (FDA) approved Kymriah CAR-T therapy for the treatment of acute lymphoblastic leukemia. In October 2017, Kite Pharma obtained FDA approval for its CAR-T cell therapy Yescarta. Kite Pharma was the second company to launch CAR-T in the market.